— Know what they know.
Not Investment Advice
Also trades as: GMVD (NASDAQ) · $vol 0M · GMVDW (NASDAQ) · $vol 0M

GMVDF OTC

G Medical Innovations Holdings Ltd
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -50.0% 1Y: +0.0% 3Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 54 · $25992 mcap · 186M float · 0.0003% daily turnover · Short 18% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.0251
Volume128
Avg Volume651
Beta-1.12
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOYacov Geva
Employees84
SectorHealthcare
IndustryMedical - Devices
IPO Date2021-06-25
5 Oppenheimer Street
Rehovot, TA 7670105
IL
972 8 958 4777
About G Medical Innovations Holdings Ltd

G Medical Innovations Holdings Ltd operates as an emerging healthcare enterprise, focused on pioneering advanced mobile health and remote medical solutions across the United States, China, and Israel. Its product line includes Prizma, an intuitive medical device for measuring vital signs, which also incorporates electronic medical record functionality and adheres to clinical-grade reporting standards. Another offering is the Extended Holter Patch System, a multi-channel biosensor worn by patients that continuously records ECG data for up to two weeks. The company is also in the process of developing a Wireless Vital Signs Monitoring System, aiming to provide uninterrupted, real-time tracking of physiological parameters and biometrics. Furthermore, G Medical Innovations offers comprehensive monitoring services, encompassing both support for independent diagnostic testing facilities and personalized private monitoring solutions. Established in 2014, the company's corporate headquarters are located in Rehovot, Israel.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms